2024 VICB Seminars
2024 Seminar Schedule
January 4: Doug Mitchell, University of Illinois at Urbana-Champaign, “Genomics-Enabled Discovery of New Molecules and Enzymes”
January 10: Peter Scott, University of Michigan, “We are Explorers in Radiochemical Space: Adventures in PET Imaging, Artificial Intelligence and Theranostics”
January 24: Matt Hall, NIH/National Center for Advancing Translational Sciences (NCATS), “Assays to Lead the Way: Drug Discovery at NCATS”
January 31: James Imlay, University of Illinois Urbana-Champaign, “How to Kill Your Neighbor: A Story About Oxidative Stress”
February 2: Erin Carlson, University of Minnesota, “Chemical Microbiology: Translation and Control of Bacterial Behavior”
February 6: Rolf Müller, Helmholtz Institute for Pharmaceutical Research, Saarland, “Approaches Towards Innovative Anti-Infectives from Microbes”
February 7: Wei Mi, Yale University, “Regulation of Escherichia coli Lipopolysaccharide Synthesis”
February 21: Libin Xu, University of Washington, “Differential Contribution of Lipid Peroxidation Mechanisms to Ferroptosis”
February 28: Jeffrey Rathmell, Vanderbilt University Medical Center, “Immunometabolism and the Microenvironment in T Cell Function”
March 1: Pei Zhou, Duke University, “Novel Antibiotics Targeting Lipid A Biosynthesis in Gram-negative Bacteria”
March 6: Mia Huang, Scripps Research, La Jolla, “Taming Glycoconjugate Structure and Interactions in Development and Disease”
March 20: Andrei Osterman, Sanford Burnham Prebys, “Experimental Evolution and Genomics of Antibiotic Resistance”
March 27: Neil Pearson, GlaxoSmithKline, “Chemical Biology Platforms to Drug the Undruggable & Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor: Antibacterial Mechanism of Action”
April 3: Heidi Hamm, Vanderbilt University, “Protease Activated Receptor 4: Regulation of Platelet Function and Role in Inflammation”
April 10: Michelle Arkin, University of California-San Francisco, “Chemical Biology Approach to Caspase-6 as a New Target in Alzheimer’s Disease.” Co-sponsored by the Department of Pharmacology.
April 11: Steven Johnson, Indiana University Medical School, “Mechanistic Insights and Strategies to Target GroEL and HSP60 Chaperonin Systems for Therapeutic Development”
April 17: John Pascal, Université de Montréal, “Structures and Mechanisms of PARP Family Enzymes” Co-sponsored by the Center for Structural Biology
September 4: Patrick Griffin, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
September 18: Emily Derbyshire, Duke University
September 25: Ronald Raines, Massachusetts Institute of Technology (MIT)
October 2: Wade Harper, Harvard Medical School
October 9: Jim Audia, FLARE Therapeutics
October 23: Andrew Goodman, Yale School of Medicine
November 6: Sam Light, The University of Chicago
November 13: Tao Che, Washington University in St. Louis
December 4: Wilfred van der Donk, University of Illinois Urbana-Champaign